MedPearls
Neuro Series 1
Cerebrovascular Emergencies
Stroke · ICH · SAH — ENLS Protocols
ENLS V1.1
⚠️ Open in Safari (iOS) or Chrome (Android) for full functionality. Do not use file preview.
🧠
ENLS · Cerebrovascular Emergencies · Neuro Series 1

Acute Stroke Initial Assessment

Clinical suspicion → Prehospital → ED assessment → Brain imaging → Branch to AIS / ICH / SAH
Stroke Triage
Out of Hospital
  • Acute onset focal neurologic symptoms
  • 911 / EMS services alerted
  • ABCs
  • Stroke screening tool
  • Time last known normal
  • Medication list — especially anticoagulants: warfarin, heparin (dialysis), LMWH (enoxaparin, dalteparin), dabigatran, apixaban, rivaroxaban — and when last taken
  • Consider triage to stroke centre
  • ABCs
  • Focused neurologic exam within 5 minutes: GCS, NIHSS
  • History: medications, atrial fibrillation
  • Labs: CBC with platelets, PT/PTT, INR, capillary glucose, EKG, beta-HCG (women)
  • IV access
  • O₂ to maintain sat >94% — hyperoxia may be detrimental, no high-flow O₂ unless needed
  • Activate stroke code system (if available)
  • Stroke MD/team to evaluate within 5 minutes
  • Determine NIHSS score
  • CT or MRI — CT is usually faster
  • Consider Stroke CT: non-contrast head CT + CTA neck and brain + CT perfusion
  • Consider MRI: MRA head and neck + DWI + MR perfusion
  • Note: tPA inclusion/exclusion decisions are based on non-contrast CT head alone
✅ NO HAEMORRHAGE — Ischaemic Stroke / Normal CT
🫀
CT/MRI: normal or ischaemic infarct → proceed to Ischaemic Stroke protocol
💥 SAH — Blood in Subarachnoid Space
💥
Predominant blood in subarachnoid space
  • Head trauma present → consider Traumatic Brain Injury protocol
  • No head trauma → likely ruptured cerebral aneurysm → SAH protocol
🩸 ICH — Blood in Brain Parenchyma
🩸
Most blood within brain parenchyma (including ventricle)
  • Head trauma present → consider Traumatic Brain Injury protocol
  • No head trauma → ICH protocol
Checklist
  • ☐ Establish time of onset (time last seen normal)
  • ☐ Vital Signs
  • ☐ Imaging (CT or MRI)
  • ☐ NIHSS
  • ☐ GCS
  • ☐ Labs: CBC, Platelets, Chemistries, PT/PTT, INR, glucose
Communication to Receiving Team
  • ☐ Age
  • ☐ Time of Onset
  • ☐ NIHSS
  • ☐ Imaging findings: primary haemorrhage, ischaemia, or normal scan
MedPearls · Neuro Series 1
🫀
ENLS · Ischaemic Stroke Protocol V1.2

Acute Ischaemic Stroke

TIA · Time windows · tPA eligibility · BP management · Endovascular · Admission orders
Ischaemic Stroke
Acute Ischaemic Stroke — CT/MRI: No haemorrhage or shows ischaemic infarctEstablish IV access · O₂ sat >94% · NIHSS within 5 min · Activate stroke code
✅ TIA — Symptoms Completely Resolved
TIA: focal neurological symptoms explainable by vascular cause, resolving within 24 hours
🟢 LOW RISK TIA — ABCD² 0–3
  • Antithrombotic: ASA 81 mg/day, Clopidogrel 75 mg/day, or ASA/extended-release dipyridamole
  • Carotid imaging: ultrasound, CTA or MRA
  • Consider echocardiography
  • If A-fib on ECG/rhythm strip → consider oral anticoagulation or LMWH (or ASA 81 mg if contraindicated)
  • Consider long-term cardiac monitoring if TIA embolic and A-fib not yet identified
  • Smoking cessation · Initiate statin
🔴 MODERATE/HIGH RISK TIA — Admit for Observation
  • Permissive hypertension (not to exceed 220/120 mmHg)
  • Telemetry
  • ASA 81 mg/day, Clopidogrel 75 mg/day or ASA/extended-release dipyridamole — unless A-fib detected
  • If A-fib: consider oral anticoagulation, IV heparin or LMWH, or ASA 81 mg/day if contraindicated
  • Carotid imaging: ultrasound, CTA or MRA · Consider echocardiography
  • Smoking cessation · Initiate statin
🔴 ACUTE ISCHAEMIC STROKE — Deficits Persist
⏱ < 3 HOURS — IV tPA Eligible Window
All must be met for inclusion
  • Diagnosis of ischaemic stroke causing measurable neurological deficit
  • Neurological signs NOT clearing spontaneously (treat stuttering/partial improvers)
  • Signs NOT minor and isolated — consider any NIHSS if deficit is devastating (isolated aphasia, hemianopsia, brainstem)
  • Caution with major deficits
  • Symptoms NOT suggestive of subarachnoid haemorrhage
  • BP < 185/110 mmHg (or reducible to this)
Exclusions — any one = exclude from tPA
  • Head trauma or prior stroke in previous 3 months
  • MI in previous 3 months
  • GI or urinary tract haemorrhage in previous 21 days
  • Major surgery in previous 14 days
  • Arterial puncture at non-compressible site in previous 7 days
  • History of previous intracranial haemorrhage
  • Active bleeding or acute trauma (fracture)
  • Oral anticoagulant with INR > 1.7
  • Direct thrombin inhibitors or Xa inhibitors (use 2-day cutoff if no lab available)
  • Heparin in previous 48h with aPTT not in normal range
  • Platelet count < 100,000 mm³
  • Blood glucose < 50 mg/dL (2.7 mmol/L)
  • Seizure with postictal neurological impairment
  • CT shows multilobar infarction (hypodensity >1/3 cerebral hemisphere)
  • Patient/family do not understand risks and benefits
✓ BP ACCEPTABLE — Administer IV tPA
IV t-PA (Alteplase) — Dose Protocol
Dose: 0.9 mg/kg IV — MAX 90 mg total 1. Place 2 peripheral IV lines 2. WEIGH patient accurately — do not estimate 3. Mix (do not shake) 0.9 mg/kg 4. 10% as IV bolus over 1–2 minutes 5. Remaining 90% infused over 1 hour
Dispensed in 50 and 100 mg bottles — draw off and discard excess to avoid overdose
Monitoring
  • Neuro check q30 min × 6h, then q1h
  • O₂ sat >94%
  • BP q15 min × 2h, then q30 min × 6h, then q1h × 16h
  • BP after reperfusion: <180/105 mmHg
  • No tPA given: permissive <220/120 mmHg
Post-tPA Rules (if tPA administered)
  • Avoid indwelling urinary catheter, NG tubes, intra-arterial catheters for 4 hours
  • No anticoagulant/antiplatelet for 24 hours
  • Repeat head CT or MRI at 24h before starting anticoagulant/antiplatelet meds
General Admission Orders
  • Bedside swallow test (30 mL water PO) before anything PO
  • Glucose <140 — consider insulin drip
  • IVF (NS) for euvolemia · Monitor for A-fib · Treat fever with antipyretics
  • Avoid indwelling urinary catheter (nosocomial infection risk)
tPA Complications — Watch For
  • Angioedema → airway obstruction → consider rapid intubation
  • Haemorrhage → STOP tPA immediately
  • Sudden neurological deterioration → likely ICH (often with marked BP rise)
  • Severe hypertension or hypotension → may signal ICH or systemic haemorrhage
If Neurological Decline During or After tPA
  • STOP tPA infusion immediately
  • STAT head CT
  • Notify neurosurgeon on call — transfer if not available
  • STAT labs: PT, PTT, Platelets, fibrinogen, type and cross 2–4 units PRBCs
  • Give: 6–8 units cryoprecipitate + 6–8 units platelets
  • Consider: 40–80 mcg/kg recombinant Factor VIIa while waiting
✓ IMPROVED
🟢
Hospital admission or transfer to stroke unit/ICU. Patient outcomes improve in a stroke centre.
✗ NO IMPROVEMENT
No improvement: no change in NIHSS within 1 hour, or <4-point improvement with debilitating symptoms remaining
  • Large vessel occlusion (MCA, intracranial ICA, basilar, vertebral) within 8-hour window
  • Suspected by hyperdense sign on CT (insensitive) — confirmed by CTA, MRA, or conventional angiography
  • Contact neurointerventional physician — if not available, consider rapid transfer to comprehensive stroke centre
  • Some centres use CT/MR perfusion to select patients (ischaemic penumbra)
✗ BP ≥ 185/110 — Reduce BP Before tPA
⚠️
BP too high for tPA — requires gentle reduction before initiating. Always start a drip — boluses wear off.
Labetalol
10 mg IV every 10 min Consider doubling: 10→20→40→80 mg Max total: 150 mg Start maintenance infusion
Nicardipine
Start: 5 mg/h IV Titrate up 2.5 mg/h every 5–15 min Max: 15 mg/h When target reached: reduce to 3 mg/h
If BP falls below 185/110 → proceed to tPA. If BP refractory → do NOT give tPA. Continue to treat BP <220/120 mmHg. Permissive HTN up to 220/120 for TIA and non-tPA patients.
⏱ 3–4.5 HOURS — Extended Window
Note: tPA not yet approved in US for 3–4.5h use; approved in Europe and Canada. Same criteria as <3h plus additional restrictions:
  • Age < 80 years
  • No anticoagulant use, regardless of INR
  • NIHSS ≤ 25
  • No combined history of prior stroke AND diabetes
If eligible → administer IV tPA using identical protocol as <3h window. Then assess for endovascular candidacy.
⏱ 4.5–8 HOURS — Outside IV tPA Window
⚠️
Beyond 4.5 hours, IV tPA is associated with ICH — do not give tPA
  • IA therapies (mechanical thrombectomy) may be helpful within 8-hour window
  • Contact neurointerventional physician — if not available and large vessel occlusion suspected, consider rapid transfer
IV tPA Exclusions
  • Time >4.5 hours
  • Contraindications (recent surgery, active bleeding at non-compressible site)
  • Large area of infarction already present (>1/3 MCA territory)
IA Exclusions
  • No large vessel occlusion on CTA/MRA
  • Lack of consent from patient or surrogate
  • Large area of infarction already present
  • If IA not available but large vessel occlusion suspected → consider rapid transfer to comprehensive stroke centre
  • Transfer if treating hospital cannot provide required level of care (no ICU)
  • Transfer if large vessel occlusion evidence and patient can arrive and be treated within 8 hours of onset
  • Patient outcomes improve if treated in a stroke centre
MedPearls · Neuro Series 1
🩸
ENLS · Intracerebral Haemorrhage Protocol V1.1

Intracerebral Haemorrhage (ICH)

BP targets · Coagulopathy reversal · ICH score · Surgery · Seizures · ICP
ICH
ICH Diagnosis ConfirmedSudden headache + progressive neurological signs · Cannot clinically distinguish ICH from ischaemia — emergent brain imaging is essential
🏥
Immediate — NeuroICU Admission Preferable
  • Primary and secondary interventions may be conducted concurrently
  • Primary = what can be done now · Secondary = ongoing management
  • ICH may continue to expand — mental status and airway may become compromised
  • Continuous airway assessment is critical — especially in posterior fossa haemorrhages
  • Intubate if: not protecting airway, hypoventilation, hypoxaemia, declining GCS
🎯
Target: Keep SBP < 140 mmHg
Nicardipine IV (preferred)
Start: 5 mg/h IV Titrate 2.5 mg/h every 5–15 min Max: 15 mg/h
Labetalol IV
20 mg IV bolus Then as needed to maintain SBP < 140 mmHg
Use nicardipine ± labetalol. Continue monitoring SBP <140 mmHg throughout admission.
Determine where the haemorrhage is located — may be more than one site:
  • Lobar · Basal ganglia · Thalamus · Cerebellum
  • Midbrain · Pons · Intraventricular
Formula: A × B × C ÷ 2
  • Select CT slice with largest ICH
  • A = longest axis (cm)
  • B = longest axis perpendicular to A (cm)
  • C = number of slices × slice thickness (cm)
  • Estimated volume of spheroid — correlates well with planimetric CT analysis (Kothari et al, Stroke 1996)
ICH Volume ≥ 30 cc = 1 point on ICH Score. ICH <30 cc = 0 points.
If IV contrast was administered during CT, extravasation of contrast within the haematoma may suggest active bleeding — this is the CT "Spot Sign" seen on CTA or post-contrast imaging. Indicates risk for haematoma expansion.
Consider: oral/parenteral anticoagulants, antiplatelet agents, DIC Warfarin / Vitamin K Antagonists — INR > 1.4
  • 4-factor PCC (preferred over FFP) + Vitamin K 10 mg IV
  • Dose formula: (Target %PC − Current %PC) × weight kg = mL of FFP or IU of PCC
INR Range% Prothrombin Complex Function
> 55%
4.0–4.910%
2.6–3.915%
2.2–2.520%
1.9–2.125%
1.7–1.830%
1.4–1.640%
1.0100%
Example: INR 7.5, target INR 1.5, weight 80 kg → (40−5) × 80 = 2,800 mL FFP or 2,800 IU PCC
DOACs — Direct Thrombin Inhibitors / Xa Inhibitors
  • No specific reversal agents — consider activated charcoal if last dose within 8 hours
  • Dabigatran: consider rVIIa 80 µg/kg
  • Rivaroxaban or Apixaban: consider PCC 30 IU/kg
  • FFP and Vitamin K are NOT effective for DOACs
Heparin — Recent Administration
  • Protamine sulfate 1 mg per 100 U heparin received in last 2 hours — maximum dose 50 mg
Antiplatelet Agents (Aspirin, Clopidogrel, Prasugrel)
  • Transfuse with platelets
  • Consider DDAVP 0.3 mcg/kg IV
  • Do NOT administer anticonvulsants prophylactically
  • Treat clinical seizures with benzodiazepines then anticonvulsants
  • Consider EEG monitoring if level of consciousness is less than expected by size and location of haemorrhage
  • Consider ICP monitoring if GCS < 8 or patient has symptomatic hydrocephalus
  • Large haematoma, intraventricular extension, or hydrocephalus = elevated risk
  • See ENLS: Elevated ICP and Herniation protocol for management
  • Cerebellar ICH — consider surgery urgently depending on size
  • Lobar ICH with mass effect — consider surgery in severely affected but salvageable patients, and as a life-saving measure in patients who are herniating
  • Urgent neurosurgical consult for cerebellar haemorrhage and large haematomas with mass effect
MedPearls · Neuro Series 1
💥
ENLS · Subarachnoid Haemorrhage Protocol V1.1

Subarachnoid Haemorrhage (SAH)

Clinical features · CT/LP diagnosis · Initial orders · BP · Hydrocephalus · Antifibrinolytics · Pain · Seizure
SAH
SAH most commonly from trauma, then ruptured intracranial aneurysm. Prevention of re-rupture can be life-saving. Classic Presentation — Aneurysmal SAH
  • Abrupt onset sudden severe headache — onset typically <1 second ("thunderclap")
  • NEW, qualitatively DIFFERENT headache for the patient
  • May have neck pain, nausea and vomiting
  • May transiently lose consciousness or present in coma
  • Nature and onset of headache is the key distinguishing feature from other stroke, syncope, seizure
Not-So-Classic Presentation — Do Not Miss
  • Headache not reported as abrupt (patient may not remember clearly)
  • Headache responds well to non-narcotic analgesics
  • Headache resolves spontaneously within hours
  • ~40% of SAH patients have a normal neurological examination — may not have meningismus — do not necessarily appear acutely ill
Key Examination Features
  • Glasgow Coma Scale (GCS)
  • Pupil exam · Fundoscopic exam for retinal haemorrhages · Neck for meningismus
See Stroke Triage tab for prehospital protocol. Indications for Intubation
  • Not protecting airway · Hypoventilation · Hypoxaemia
  • Expected decompensation during transport within or between hospitals
📷
Non-contrast CT — Gold standard for SAH (Class 1, LOE B)
  • Most sensitive in first hours — by 3 days, only ~85% sensitive
  • False negative causes: anaemia, low-volume SAH, technically poor scan
  • CTA at time of CT may help identify intracranial aneurysm — but negative CTA alone does NOT rule out SAH
  • MRI useful if imaging done days after SAH — specific sequences can detect subarachnoid blood
✓ CT CONFIRMS SAH
SAH confirmed — LP not necessary. Proceed to initial orders and management.
✗ CT NEGATIVE — LP Mandatory
CT sensitivity for recent SAH ~95% — you can miss 5 in 100 with CT alone. If clinical suspicion, LP is obligatory (Class 1, LOE B).
LP done to look for xanthochromia — staining of CSF by heme breakdown products (chiefly bilirubin). Takes several hours to develop after bleed. Typical SAH Findings in CSF
  • RBCs present
  • <5 WBCs · WBC:RBC ratio 1:700
  • Xanthochromia present
  • Minimal clearing of RBCs between tubes 1 and 4
Interpretation
  • Xanthochromia present → SAH confirmed (false positive if CSF protein >100 mg/dL)
  • Clear CSF, no xanthochromia → SAH highly unlikely; but if you still clinically suspect aneurysm → emergent consultation
  • RBCs in tube 1 and 4 equally, LP done in first few hours → SAH likely
Atypical / Inconclusive Findings
  • Clearing from tube 1 to 4 → may be traumatic tap
  • RBCs tubes 1 and 4 equal but LP done within 4h → cannot distinguish SAH vs traumatic tap
  • No xanthochromia but LP >12h after headache → bleed may have been too small
  • Excessive WBCs (WBC:RBC >1:700) → suggests meningitis or encephalitis
Time dependency: CT most sensitive early; RBCs in CSF seen early and clear with time; xanthochromia absent early, nearly always present by 12h after bleed
SAH Confirmed (by CT or LP)
  • Goal: reduce chance of aneurysm re-rupture, expedite aneurysm treatment, prevent medical complications
  • Bed rest (Class 2B, LOE B)
  • Pre-operative labs: CBC, Platelets, PT/PTT, electrolytes, BUN, Cr, cardiac enzymes
  • 12-lead ECG
  • Cardiac telemetry
  • Nimodipine 60 mg PO/NG — watch for hypotension
🎯
Target: SBP < 140–150 mmHg
  • Many specialists recommend SBP <140 in patients with no history of hypertension
  • SBP >150 has been associated with aneurysmal re-rupture
  • Over-treatment of BP can lead to brain ischaemia — especially if hydrocephalus present
Preferred — Short-acting, Titratable
  • Labetalol IV
  • Nicardipine IV
  • Avoid long-term nitroprusside — concern of raising ICP
  • Caused by blockage of CSF absorption — diagnosed on head CT (dilated ventricles)
  • If obtunded or comatose → EVD (external ventricular drain) by neurosurgeon or neurointensivist — treats hydrocephalus and monitors ICP
  • If no neurosurgeon available: Mannitol 1 g/kg and expedite transfer to neurosurgical facility within the next hour
  • Amicar or tranexamic acid can reduce aneurysmal re-rupture
  • Risk: raise risk of DVT, PE, ischaemic stroke if continued
  • If free of recent MI, DVT/PE, or hypercoagulable state → many centres administer until aneurysm secured (Hillman et al, J Neurosurg 2002)
Straining, Valsalva, writhing can cause aneurysm re-rupture. Do NOT over-sedate — could mask hydrocephalus symptoms.
  • IV medications with short half-lives — Fentanyl IV
  • Liberal anti-emetics if vomiting occurs
  • BP control is enhanced with adequate analgesia
  • Anxiety: small doses Lorazepam IV
  • PRO: Seizures before definitive aneurysm treatment → associated with re-rupture and raised ICP
  • CON: Phenytoin use associated with worse cognitive outcomes
  • One strategy: loading dose phenytoin in ED, continue until aneurysm secured, then stop unless seizures have occurred (Class 2B, LOE B)
Early (within first hour) neurological decompensation:
  • Re-rupture of aneurysm → repeat head CT diagnostic
  • Worsening hydrocephalus → repeat head CT, EVD urgently needed, give Mannitol while arranging EVD
  • Seizure → treat with phenytoin load
  • Cardiopulmonary cause → neurogenic pulmonary oedema, catecholamine cardiomyopathy; worsening hypoxia (get CXR); falling BP → urgent echocardiogram; cardiovascular collapse may signal cerebral herniation from re-rupture or untreated hydrocephalus
  • Platelet count <50,000 → administer 6-pack platelets
  • Warfarin/Vitamin K antagonists: 4-factor PCC (preferred) or FFP + Vitamin K 10 mg IV
  • DOACs: same approach as ICH — see ICH tab
See ICH tab for full PCC dosing table and calculation.
MedPearls · Neuro Series 1
📊
Interactive Calculators & Reference Scales

Scoring Tools

ABCD² · ICH Score · GCS · Hunt-Hess · WFNS · NIHSS
Scores
🫀 ABCD² Score — TIA Stroke Risk
Score: 0 — Low Risk (0–3)
RiskScore2-day %7-day %90-day %
Low0–31.01.23.1
Moderate4–54.15.99.8
High6–78.11218
Ref: Cucchlara B et al, Ann Emerg Med 2008, 52:S27-39
🩸 ICH Score Calculator
Score: 0 / 6
ComponentResponseScore
Eye Opening (E)Spontaneous4
To voice3
To pain2
None1
Verbal (V)Oriented5
Confused4
Words only3
Sounds only2
None1
Motor (M)Obeys commands6
Localises pain5
Withdraws4
Flexion (decorticate)3
Extension (decerebrate)2
None1
Total GCS = E + V + M · Range 3–15 · GCS ≤8 = severe brain injury / consider ICP monitoring
GradeClinical Features
1Asymptomatic, mild headache, slight nuchal rigidity
2Moderate to severe headache, nuchal rigidity, no neurologic deficit other than cranial nerve palsy
3Drowsiness/confusion, mild focal neurologic deficit
4Stupor, moderate-severe hemiparesis
5Coma, decerebrate posturing
GradeGCSMotor Deficit
115Absent
213–15Absent
313–15Present
47–12Present or absent
53–6Present or absent
ItemDomainRange
1aLevel of consciousness0–3
1bLOC questions0–2
1cLOC commands0–2
2Best gaze0–2
3Visual fields0–3
4Facial palsy0–3
5a/5bMotor arm (left/right)0–4 each
6a/6bMotor leg (left/right)0–4 each
7Limb ataxia0–2
8Sensory0–2
9Best language0–3
10Dysarthria0–2
11Extinction/Inattention0–2
Total range: 0–42 · 0=no stroke · 1–4 minor · 5–15 moderate · 16–20 moderate-severe · 21–42 severe
MedPearls · Neuro Series 1
📋
ENLS Checklists & Communication Points

Clinical Checklists

Acute Stroke · Ischaemic Stroke · ICH · SAH — all in one place with quick BP reference
Checklists
Checklist
  • ☐ Establish time of onset (time last seen normal)
  • ☐ Vital Signs
  • ☐ Imaging (CT or MRI)
  • ☐ NIHSS
  • ☐ GCS
  • ☐ Labs: CBC, Platelets, Chemistries, PT/PTT, INR, glucose
Communication
  • ☐ Age
  • ☐ Time of Onset
  • ☐ NIHSS
  • ☐ Imaging findings: primary haemorrhage, ischaemia, or normal scan
Checklist
  • ☐ Vital signs
  • ☐ Medication list — especially anticoagulants (warfarin, heparin, LMWH, dabigatran, apixaban, rivaroxaban) and when last taken
  • ☐ Labs: capillary glucose, CBC with platelets, PT/PTT, INR, EKG, beta-HCG (women)
  • ☐ IV access
  • ☐ O₂ to maintain saturation >94%
  • ☐ Activate stroke code system (if available)
  • ☐ Determine NIHSS score
Communication
  • ☐ Age
  • ☐ Airway status
  • ☐ Time of symptom onset
  • ☐ NIHSS
  • ☐ CT or MRI results
Checklist
  • ☐ Check PT, PTT, INR
  • ☐ Head Imaging Results: Haematoma volume (ABC/2)
  • ☐ GCS
  • ☐ Calculate ICH Score
Communication
  • ☐ Age
  • ☐ ICH Volume
  • ☐ GCS
  • ☐ ICH Score
  • ☐ Hydrocephalus present?
Checklist
  • ☐ Brain Imaging (non-contrast CT head)
  • ☐ Labs: PT/PTT, CBC, electrolytes, BUN, Cr, troponin
  • ☐ 12-lead ECG
  • ☐ LP if CT negative and clinical suspicion remains
Communication
  • ☐ Clinical presentation: level of consciousness, motor exam, pupil exam
  • ☐ WFNS score and Hunt-Hess Grade
  • ☐ Imaging/LP results
  • ☐ Hydrocephalus present?
  • ☐ Airway status
  • ☐ Sedation and other medications given
  • ☐ Coordination of other vascular imaging (CTA/MRA/angiography)
SyndromeBP TargetPreferred Agents
AIS — Pre-tPA< 185/110Labetalol, Nicardipine
AIS — Post-tPA< 180/105Labetalol, Nicardipine
AIS — No tPA< 220/120 (permissive)Avoid aggressive lowering
ICHSBP < 140Nicardipine ± Labetalol IV
SAHSBP < 140–150Labetalol, Nicardipine (avoid long-term nitroprusside)
MedPearls · Neuro Series 1
For educational use only · Based on ENLS (Emergency Neurological Life Support) Protocols · Not a substitute for clinical judgment · MedPearls Neuro Series 1
MedPearls · Neuro Series 1
Cerebrovascular Emergencies · ENLS 2025
🔗 More Tools at MedPearls Store